3457501e-figure-01 (3457501e Figure 01)
Losartan Potatssium
Product Images NDC 58517-240
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Losartan Potatssium (NDC 58517-240). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by New Horizon Rx Group, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
3457501e-figure-02 (3457501e Figure 02)
This appears to be a result summary of a clinical trial comparing the medications Atenolol and Losartan Potassium. The data shows that 9% of the patients achieved the primary endpoint, and the adjusted risk reduction was 13% with a p-value of 0.021. The table shows various study months and potentially some numerical results associated with them, but without more context it is difficult to determine their meaning.*
3457501e-figure-03 (3457501e Figure 03)
This text is not-available since it only lists medication names and some symbols.*
3457501e-figure-04 (3457501e Figure 04)
3457501e-figure-05 (3457501e Figure 05)
This document is describing the results of a clinical trial involving Losartan Potassium Tablet and a placebo. It states that 9% of patients experienced an event, and that there was a 16.1% risk reduction with Losartan Potassium Tablet compared to the placebo. The value of p is 0.022. The meaning of "12 2 % 48" is not clear from this text and may be a scanning error.*
3457501e-figure-06 (3457501e Figure 06)
This is a description of Losartan Potassium Tablets, USP with NDC number 58517-240-30, containing 30 tablets of 0mg strength. The remaining text seems to be garbled or not relevant.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
